REPAGLINIDE VIATRIS 0.5 mg, tablet 90 tablets, CIP 3400930208977
Active ingredients: Repaglinide
Commercialized according to BDPMDispensing in France: Prescription only
Tablet90 tablets, CIP 3400930208977orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- REPAGLINIDE VIATRIS 0,5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 90 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Apr 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61569137CIP73020897CIP133400930208977Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RÉPAGLINIDEcomprimé | 0,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.